HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Continuous-infusion spirogermanium for the treatment of refractory carcinoma of the ovary: a phase II trial.

AuthorsJ J Kavanagh, P B Saul, L J Copeland, D M Gershenson, I H Krakoff
JournalCancer treatment reports (Cancer Treat Rep) Vol. 69 Issue 1 Pg. 139-40 (Jan 1985) ISSN: 0361-5960 [Print] United States
PMID3967257 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antineoplastic Agents
  • Organometallic Compounds
  • Spiro Compounds
  • Germanium
  • spirogermanium
Topics
  • Adult
  • Aged
  • Antineoplastic Agents (administration & dosage, adverse effects, therapeutic use)
  • Drug Evaluation
  • Female
  • Germanium (administration & dosage, adverse effects, therapeutic use)
  • Humans
  • Infusions, Parenteral
  • Middle Aged
  • Organometallic Compounds
  • Ovarian Neoplasms (drug therapy)
  • Spiro Compounds (administration & dosage, adverse effects, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: